Equity
Treasury Stock
Bristol-Myers Squibb Treasury Stock decreased by 0.0% to $43.59B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $43.68B to $43.59B. Over 4 years (FY 2020 to FY 2024), Treasury Stock shows an upward trend with a 13.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025
How to read this metric
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Detailed definition
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Peer comparison
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
Metric ID:
treasury_stockHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.20B | $28.57B | $31.26B | $35.19B | $35.29B | $36.41B | $38.62B | $38.81B | $39.68B | $43.08B | $43.77B | $43.70B | $43.69B | $43.68B | $43.66B | $43.60B | $43.59B | $43.59B |
| QoQ Change | — | +1.3% | +9.4% | +12.6% | +0.3% | +3.2% | +6.1% | +0.5% | +2.2% | +8.6% | +1.6% | -0.2% | -0.0% | -0.0% | -0.0% | -0.1% | -0.0% | -0.0% |
| YoY Change | — | — | — | — | +25.2% | +27.4% | +23.5% | +10.3% | +12.4% | +18.3% | +13.3% | +12.6% | +10.1% | +1.4% | -0.3% | -0.2% | -0.2% | -0.2% |
Range$28.20B – $43.77B
CAGR+10.8%
Avg YoY Growth+11.0%
Median YoY Growth+11.4%
Current Streak7 quarters decline
Treasury Stock at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's treasury stock?
- Bristol-Myers Squibb (BMY) reported treasury stock of $43.59B in Q3 2025.
- How has Bristol-Myers Squibb's treasury stock changed year-over-year?
- Bristol-Myers Squibb's treasury stock decreased by 0.2% year-over-year, from $43.68B to $43.59B.
- What is the long-term trend for Bristol-Myers Squibb's treasury stock?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's treasury stock has grown at a 13.6% compound annual growth rate (CAGR), from $26.24B to $43.66B.
- What does treasury stock mean?
- The value of shares a company has bought back from the market.